SureTrader SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Egalet Corporation (EGLT)

EGLT RSS Feed
Add EGLT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 1/13/2017 9:14:04 PM - Followers: 41 - Board type: Free - Posts Today: 0

Egalet Corporation 460 East Swedesford Road Suite 1050 Wayne, PA 19087 United States - Map Phone: 610-833-4200 Website: http://www.egalet.com Egalet Corporation, a specialty pharmaceutical company, is engaged in developing planning to commercialize proprietary, abuse-deterrent pharmaceutical products for the treatment of pain and other indications. It develops various clinical-stage opioid-based product candidates through its technology platform in tablet form that are specifically designed to deter abuse by physical and chemical manipulation while also providing tailored release of the active pharmaceutical ingredient. The company’s product candidates include Egalet-001 and Egalet-002 that are abuse-deterrent, extended-release, oral formulations for the treatment of moderate and severe pain. It is also developing a portfolio of preclinical abuse-deterrent product candidates for the treatment of pain and other conditions. The company was founded in 2010 and is headquartered Wayne, Pennsylvania.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EGLT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
EGLT News: Current Report Filing (8-k) 01/09/2017 04:57:38 PM
EGLT News: Egalet Receives FDA Approval for ARYMO™ ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Ab... 01/09/2017 02:51:00 PM
EGLT News: Current Report Filing (8-k) 01/09/2017 09:02:32 AM
EGLT News: Statement of Changes in Beneficial Ownership (4) 01/04/2017 05:00:38 PM
EGLT News: Statement of Changes in Beneficial Ownership (4) 01/04/2017 05:00:14 PM
PostSubject
#266   FDA confirms Egalet's story. WeeZuhl 01/13/17 09:14:04 PM
#265   Of course the vulture law firms start their B.S.!!! Aloha922 01/13/17 08:05:48 AM
#264   ksviking12: I hear U. My problem bbotcs 01/12/17 11:36:31 AM
#263   60% short interest on what looks to be ksviking12 01/12/17 09:51:54 AM
#262   Warning: I lost quite a few dollars bbotcs 01/11/17 04:34:17 PM
#261   after. It was linked in Bret Jensen's SA article. realfast95 01/11/17 04:30:53 PM
#260   Was that after the FDA Bullshit or before. diddobuyer 01/11/17 04:26:31 PM
#259   1/11/2017 JMP Securities Reiterated Rating Outperform $15.00 realfast95 01/11/17 11:00:12 AM
#258   Biotech Forum Daily Digest: Keytruda Continues To Power realfast95 01/11/17 10:31:03 AM
#257   Egalet Corp Receives a Buy from Cantor Fitzgerald realfast95 01/11/17 10:29:18 AM
#256   realfast95: Thank U for the real fast response! bbotcs 01/10/17 03:17:35 PM
#255   morphabond's product isn't available for sale yet. realfast95 01/10/17 03:13:05 PM
#254   Next drug. Won't the abuse-deterrent version of bbotcs 01/10/17 03:04:04 PM
#253   Hi, I'm new to the board and to bbotcs 01/10/17 03:02:56 PM
#252   Is there a competing product or products? Giovanni 01/10/17 02:57:01 PM
#251   they already have two products and sales team realfast95 01/10/17 11:25:44 AM
#250   Now comes the hard part, they have to Giovanni 01/10/17 11:22:21 AM
#249   no one can win the label war. No realfast95 01/10/17 10:40:09 AM
#248   In my opinion they did not deny them Aloha922 01/10/17 10:33:00 AM
#247   Impact of Exclusivity on Approval of Arymo ER realfast95 01/10/17 10:07:44 AM
#246   IF it gets anywhere below $6 I will add. girlfriend 01/10/17 10:03:00 AM
#245   EGLT – Gabelli & Co. cuts to a realfast95 01/10/17 10:01:50 AM
#244   Target $5.50 :) Emptyhead 01/10/17 09:59:57 AM
#243   Finally in EGLT again here at 6.60 very oversold….duh! girlfriend 01/10/17 09:43:12 AM
#242   The analysts may have to reduce their PT's girlfriend 01/10/17 09:13:15 AM
#241   Strap in boys and girls this is going Aloha922 01/10/17 09:09:34 AM
#240   need analysts to step up. They were on realfast95 01/10/17 08:45:44 AM
#239   How does a company get exclusivity on a Aloha922 01/10/17 07:36:19 AM
#238   Listen to the call. The market has misunderstood Areader 01/09/17 10:35:13 PM
#237   FDA screw-over on the Nasal. Exclusivity shows up realfast95 01/09/17 08:55:48 PM
#236   nuttin wrong with takin profits, I'm in small gdog 01/09/17 08:29:32 PM
#235   EGLT - here is why the shorts (61% value1008 01/09/17 08:24:59 PM
#234   8pm EST conference calls….who knows! girlfriend 01/09/17 06:46:54 PM
#233   Took profits AH. No reason for short squeeze INTL 01/09/17 06:39:59 PM
#232   this influential tweeter killed the stock with this tweet realfast95 01/09/17 05:28:29 PM
#231   ahhh thxs, i got a few at gdog 01/09/17 05:02:59 PM
#230   No confirmation of the wording on the label. Aloha922 01/09/17 05:01:41 PM
#229   why hasn't this held its gains? gdog 01/09/17 04:58:24 PM
#228   On watch and thanks GOINGUP-AGAIN 01/09/17 04:30:13 PM
#227   https://www.benzinga.com/general/biotech/17/01/8884993/egalets-fda-approval-may- INTL 01/09/17 04:27:03 PM
#226   they didn't get the anti abuse labeling they diddobuyer 01/09/17 04:15:44 PM
#225   Ain't going anywhere cause I'm in biggly. pgh_maulers 01/09/17 04:10:16 PM
#224   EGLT FDA approval with a 60% short interest. INTL 01/09/17 04:01:46 PM
#223   Strong Close! AquaFinance 01/09/17 04:00:23 PM
#222   Yep, there is a lot more run in Kung Fu Panda 01/09/17 03:57:30 PM
#221   coming back up :) got in close to Mistr Tommy 01/09/17 03:54:44 PM
#220   This is 60% short. Sit back and watch INTL 01/09/17 03:52:41 PM
#219   It's bs because all pills can be taken realfast95 01/09/17 03:36:32 PM
#218   label issue - bs realfast95 01/09/17 03:33:30 PM
#217   This just smells bad. G3TCRUNK3R 01/09/17 03:33:19 PM
PostSubject